ED
Editas Medicine, Inc.
EDIT · NASDAQ
$2.71 +1.50% (+$0.04)
1M -5.90%
Market Cap $415.9M
P/E Ratio -
Div. Yield -
ROE 196.63%
Bulios Fair Price
$2.51
7.4% downside
Trenutna cena
$2.71
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica EDIT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
26 /100
Expensive P/S 8.85x
P/B 3.95x
P/E N/A
Growth
78 /100
Growing Rev. growth 27.15%
Book val. growth 57.71%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 56.90%
FCF margin 256.46%
Net margin 157.32%
Quality
3 /100
Poor ROIC 46.81%
Asset turnover 0.20x
ROE 196.63%
Debt
100 /100
Low Debt/Equity 0.15x
Int. coverage 34.55x
Current ratio 3.19x
Stability
13 /100
Unstable Beta 2.09x
Profitable years 0
Rev. volatility 185.50%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EDIT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gilmore O'Neill
Employees
87
Headquarters
Cambridge
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report